Zoe’s approach to scoring companies at different maturity stages. A pre-seed company is judged differently than a PE portfolio company — at pre-seed, C-Suite Health and Vision & Strategy dominate; at growth stage, Financial Vitality and Delivery & Execution carry more weight. Stage-weighted scoring prevents apples-to-oranges comparison across a mixed portfolio.
A pre-seed startup with a visionary founder but chaotic execution is not the same risk profile as a Series C company with operational scale but slowing product innovation. Stage-weighted scoring prevents false negatives and false positives across a mixed portfolio. A PE portfolio needs different early warning signals at different stages—C-Suite burnout matters more at seed stage when the founder is doing everything; Financial Vitality and Delivery matter more at growth stage when the model is unproven. Stage-weighted scoring ensures you're comparing apples to apples within cohorts and prioritizing the right operational levers.
Zoe applies different dimension weightings based on company stage. Pre-seed companies weight Vision & Strategy and C-Suite Health higher; growth-stage companies weight Financial Vitality and Delivery & Execution higher; mature portfolio companies weight Risk and Market & Competition higher. This approach ensures the Zoe Score reflects what matters most at that stage, making benchmarking against peer cohorts (other pre-seed, other growth stage, etc.) meaningful for portfolio decision-making.
You have a deal on the table. Run a Zoe diagnostic before you sign.
Join 200+ firms on the waitlist
